WHAT THIS PAPER ADDS Endovascular treatment seems to be a potential option in patients with type A dissection at prohibitive risk for open surgery. At the moment there are only few reports in the literature and the technique is not standardised. This article underlines a preoperative study method and an operative technique. We hope it may be useful for surgeons approaching this new endovascular frontier.
Type A aortic dissection (TAAD) is a cardiovascular catastrophe associated with high mortality. Medical treatment is associated to poor outcome with a mortality rate around 60%. 1, 2 Open surgical repair is the standard treatment for TAAD despite a high mortality/morbidity rate especially in high-risk patients, reported up to 60%. 3, 4 Because mortality is strongly related to both preoperative conditions of these patients and the invasiveness of the interventions, a less invasive approach would be highly beneficial.
Over the last decades endovascular therapies have emerged as the therapy of choice in patients with descending thoracic and abdominal aortic diseases. 5 The introduction of new techniques and extensive experiences have broadened the indications for these interventions, and even diseases affecting the ascending aorta can be treated. Primary reports focussed on retrograde type A dissections affecting the aortic arch in which the primary entry tear was located in the descending segment. These patients were treated by stent graft placement in the descending aorta. 6 Currently, stent graft placement in the ascending aorta for the treatment of aneurysms, pseudoaneurysms, penetrating ulcers, intramural haematoma and even type A dissections has been described in anecdotical reports. 7e9 Computed tomographic (CT) scan imaging studies show that endovascular repair is anatomically feasible in about 30% of patients with type A dissection with a proximal entry tear in the ascending aorta. This percentage of patients may increase up to 39% with the use of extra-anatomic bypass, like a left to right carotide carotid bypass, in order to obtain an adequate distal landing zone. 10, 11 In this study we present our initial experience with endovascular repair for TAAD patients by placement of a stent graft in the ascending aorta.
METHODS

Patient selection
Patients admitted to our institution with TAAD were evaluated by cardiac surgeons. Those considered at high risk for open ascending aortic repair and suitable for endovascular repair underwent a stent graft placement in the ascending aorta through an open femoral artery access. Inclusion criteria were: (1) entry tear in the ascending aorta; (2) distance between sinotubular junction and entry tear of at least 2 cm; (3) distance between entry tear and brachiocephalic trunk of at least 0.5 cm; (4) no signs of cardiac tamponade or severe aortic regurgitation; (5) no signs of ischaemia of aortic branches and (6) adequate femoral and iliac arteries. Patients with cardiac revascularisation from ascending aorta were excluded.
The option of stent graft placement was discussed with the patient, too. The patient agreed to undergo this procedure and written informed consent was obtained.
Imaging
Computed tomography angiography (CTA) images were acquired on multislice CT scan with a 0.625-mm detector configuration (manufacturer GE VCT 64 MD light speed, General Electric, Little Chalfont, Buckinghamshire, UK). Noncontrast images were first obtained and followed by acquisition of 1.25-mm axial images and retroreconstruction at 0.625 mm from the origin of carotid arteries to the femoral arteries after intravenous injection of 80e90 ml of non-ionic contrast (400 mg ml À1 ). Subsequently, the acquired CTA data sets were transferred to a workstation (OsiriX 3.9.4 e 64 bit) for analysis. A central lumen line was generated and the distance between the entry tear and the sinotubular junction and innominate artery were measured (Fig. 1 ). Stent graft selection was based on the aortic diameter measured at the level of the entry tear, with at least 10% oversizing in respect to the true lumen, but not exceeding the original aortic diameter. We performed a 20% of oversizing in case of previous ascending aortic graft replacement (20% of oversizing with respect to the graft diameter). The presence of pericardial effusion and aortic regurgitation was investigated with the use of trans-oesophageal echocardiography (TEE).
Procedure
All the procedures were performed under general anaesthesia, with a surgical femoral access. A guide wire was introduced in three cases through a percutaneous right brachial access into the arch and descending aorta as a rescue for supra-aortic vessels. In one case a reversed left common carotid (LCC) to right common carotid (RCC) and right subclavian artery (RSA) bypass was performed to obtain an adequate distal landing zone; an Amplatzer vascular plug II e 22 mm (St. Jude Medical, Playmouth, Minnesota, USA) was used to occlude the origin of the brachio-cephalic trunk. Through the femoral artery a Landerquist stiff guide wire (COOK, Inc., Bloomington, IN, USA) was positioned into the left ventricle. Under fluoroscopic guidance the graft was advanced into the ascending aorta. We used a standard Cook Zenith TX2 in one case and an offthe-shelf device for the ascending aorta (Cook, Inc., Bloomington, IN, USA) in two patients. Before deployment of the graft an angiography was performed to check for additional entry tears and extension of the dissection. Cardiac pacing (180 beats/min) was used to reach systolic blood pressure up to 40e60 mmHg to prevent dislodgement of the stent graft during deployment. Through a right common femoral vein we placed a temporary ventricular pacing wire in the apex of the right ventricle. TEE and completion angiography were used to verify the competence of the aortic valve, check the patency of the coronary arteries and supra-aortic branches and to evaluate the exclusion of the dissection.
RESULTS
Between April 2009 and June 2012, 37 patients with TAAD were submitted to the Emergency Department of our hospital, at the cardiac surgery department. Nine of them were considered at high risk for open surgery because of comorbidities and/or previous sternotomy. The anatomic characteristics of these patients were studied for an endovascular approach and four of them respected our inclusion criteria and were addressed to a stent graft position in the ascending aorta (two males: mean age 70 years; Table 1 ). All patients were smokers and had hypertension; one patient had atrial fibrillation. One patient had prior aortic valve repair and two patients had previous ascending aortic repair for TAAD (in one of them the ascending aortic repair was associated to the aortic valve replacement) with a residual entry tear in the ascending aorta. The patients with previous ascending aortic repair were first treated with analgesic and anti-hypertensive therapies without results. Three patients were operated in acute setting (<8 h after acute onset of symptoms), one of these because of brachiocephalic trunk symptomatic dissecting dilatation (32 mm, no neurologic signs, neck pain not responding to medical therapy) occurring 48 months after ascending aorta replacement. In one case the procedure was delayed (48 h). Mean operating time was 128 min (range 90e215 min). An LCCeRCCeRSA bypass was performed in one case. Technical success was achieved in 100% of the patients, with complete exclusion of the entry tear. Stent graft length ranged between 55 and 81 mm and diameter between 35 and 40 mm. No death was registered during follow-up (range 4e39 months, mean 15 months). One patient experienced a pulmonary oedema 2 months after the procedure, not operative related. Control CT scans demonstrated no migration of the graft. A complete false lumen thrombosis of the ascending aorta was obtained in three patients, whereas in one case the false lumen in the ascending aorta was still patent, without aortic enlargement. This patient remains asymptomatic at 9 months' follow-up. In two patients the complete false lumen thrombosis of the descending thoracic aorta was obtained, whereas in the other two patients only a partial false lumen thrombosis was obtained (Tables 2 and 3 ).
DISCUSSION
With increasing aged population the incidence of TAAD is rising, especially in the elderly group. 12 In these patients open surgical repair is indicated, with graft replacement of the ascending aorta and, in the presence of aortic regurgitation, with valve resuspension or replacement. It has been reported that both preoperative clinical condition of the patient and invasive character of such procedures are associated with high mortality rates, ranging up to 60% in octogenerians.
2e4 Medical therapy alone has a comparable or even worse outcome, and therefore less invasive treatment options, such as endovascular therapies, might be beneficial.
1,2 Our study confirmed that, in a small selected subset of patients, stent graft placement in the ascending aorta for TAAD is feasible and may represent an effective and safe procedure.
In 2000 Dorros et al. reported the first case of TAAD treated with an endovascular technique through a transseptal approach. 13 Since then several authors have published their experiences, but the current literature remains sparse (Table 4) . Ye et al. reported the largest series consisting of 10 patients with only midterm follow-up. 14 These results seem promising if we consider the high-risk patients and their poor prognosis.
As the landing zones are located very close to the coronary and innominate arteries, stent graft placement in the ascending aorta may be performed only in selected cases. Two studies have been conducted to investigate the feasibility of stent graft placement in type A dissections. 10, 11 Moon et al. showed that in 162 patients with TAAD 32% were anatomically suitable for endovascular repair as there was the absence of valvular involvement and appropriate length and diameter of proximal sealing zones. 10 Hybrid procedures could be used to extend the applicability by combining a supra-aortic debranching procedure with endovascular stent graft placement. We performed this in one patient (Fig. 2) . The use of a left-to-right carotid bypass can increase the feasibility of endovascular treatment of the ascending aorta up to 40% of all TAAD patients.
11
A thorough understanding of the anatomical limits of the aortic dissection and the adjacent anatomy is a prerequisite before such procedures are performed. Identification of the primary entry tear is essential for the success of stent grafting, although this may be a difficult process. The development of multi-detector-slice CT scanners and postprocessing software has resulted in superior imaging with less artefacts, improving the sensitivity and specificity of this imaging modality. 15, 16 Three-dimensional reconstructions and virtual endoluminal imaging can be useful to assess the size and location of the intimal tear and to determine the precise length and diameter of the stent graft for successful exclusion of the dissection. 17 Other radiologic findings, such as pericardial effusion, aortic diameter, the diameters of true and false lumen and the status of thrombosis of the false lumen, may be helpful in planning the procedure. 18 Endovascular procedures in TAAD patients harbour considerable risks. The aortic arch manipulation with guide wires and stent grafts can lead to extension of dissection or dislodgement of thrombus. To avoid such complications, in selected cases, a right carotid artery access for the stent graft can be used. This is also associated with an increased risk of stroke, so we preferred to perform all procedures from a femoral route. Aortic valve insufficiency is another important complication, which is associated with aortic dilatation due to the stent graft. This complication might be related to excessive oversizing. 19 Based on this observation we adopted a maximum oversizing of 10%. A complete TEE should be performed in all cases to assess cardiac and aortic valve function, in combination with an angiography to confirm the patency of the supra-aortic branches and coronary arteries. Development of novel devices and techniques and increasing experience in these types of procedures are fundamental, before these techniques can be widely adopted. In our experience we used in three cases a device specifically designed from Cook for the ascending aorta, with a longer shaft (100 cm) and a short tip (2 cm) (Fig. 3) . Recently Metcalfe et al. published their experience with the implementation of a stent in a TAAD patient, designed specifically for ascending aorta, consisting of a 65-mm covered component and proximal and distal bare stents. 20 Although the use of bare stents in aortic dissections remains highly debated, as it may induce a new dissection or a re-entry tear, the results of these developments, in combination with other studies, are eagerly awaited. 21, 22 Our experience is limited to a small, atypical, number of patients with TAAD. Three of them had previous cardiac surgery. In these patients the natural risk of retrograde dissection, cardiac tamponade or aortic rupture was lower. A re-intervention was necessary because of the medical therapy failure, but open surgery was considered at high risk by a multidisciplinary team at our institute.
Again, previous ascending aortic replacement is another bias of this group of patients because it certainly eliminates the risk of retrograde dissection during TEVAR. However, the presence of a mechanical aortic valve made the procedure more technically demanding.
We propose endovascular treatment of the ascending aorta in a very selected number of cases and still consider open repair the gold standard.
CONCLUSION
Endovascular treatment of TAAD by placement of a stent graft in the ascending aorta is a challenging procedure due to the proximity of the aortic arch branches and coronary arteries. Our experience shows that this technique is feasible in selected patient categories, and it seems associated with favourable results. Before this therapy can be implemented in the daily practice, further research is mandatory.
